HD:
I agree that number 2 option is the best opportunity for SH's. I don't want to wait anymore years for a profit.
A trade sale, large upfront or buyout of the hydrotrope IP is what I hope for.
What we should all agree on is that SUDA has assets that can be monetised; when and how much are unknown.
Artimist
WC
Hydrotrope IP, either individually or as a whole.
These offer a lot of hope compared to many peer micro biotechs, who may only have a potential drug in phase 1 or 2 trials. These may be blockbusters eventually or nothing at all.
Hopefully the above will be sold and give us all a lift.
Road to nowhere, page-124
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.0¢ |
Change
-0.005(2.70%) |
Mkt cap ! $192.7M | |||
| Open | High | Low | Value | Volume |
| 18.5¢ | 18.5¢ | 18.0¢ | $75.50K | 409.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 595044 | 18.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.5¢ | 183170 | 7 |
View Market Depth
| Last trade - 15.32pm 05/11/2024 (20 minute delay) ? |
| ALA (ASX) Chart |